{"status":"OK","data":{"id":3196230,"identifier":"DVN/ZSCLQA","persistentUrl":"https://doi.org/10.7910/DVN/ZSCLQA","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2018-08-16","storageIdentifier":"s3://10.7910/DVN/ZSCLQA","latestVersion":{"id":150442,"storageIdentifier":"s3://10.7910/DVN/ZSCLQA","versionNumber":6,"versionMinorNumber":1,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2019-02-19T21:17:56Z","releaseTime":"2019-02-19T21:17:56Z","createTime":"2019-02-19T21:17:32Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Supporting Data for: The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Pisani, Elizabeth"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Erasmus University"},"authorIdentifierScheme":{"typeName":"authorIdentifierScheme","multiple":false,"typeClass":"controlledVocabulary","value":"ORCID"},"authorIdentifier":{"typeName":"authorIdentifier","multiple":false,"typeClass":"primitive","value":"0000-0002-3674-631X"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Nistor, Adina-Loredana"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Erasmus University"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Hasnida, Amalia"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Migunani"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Parmaksiz, Koray"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"VU Amsterdam"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Xu, Jingying"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"London School of Hygiene and Tropical Medicine"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Kok, Maarten"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Erasmus University"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Pisani, Elizabeth"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"Ternyata Ltd"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"pisani@ternyata.org"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"These data provide supplementary information for readers of the draft paper: The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study."},"dsDescriptionDate":{"typeName":"dsDescriptionDate","multiple":false,"typeClass":"primitive","value":"2018-07-27"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences","Social Sciences"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Medicine quality"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Substandard medicine"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Falsified medicine"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Counterfeit medicine"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"political economy"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"China"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Indonesia"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Turkey"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Romania"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Pharmaceutical market"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Health systems"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Universal Health Coverage"}}]},{"typeName":"topicClassification","multiple":true,"typeClass":"compound","value":[{"topicClassValue":{"typeName":"topicClassValue","multiple":false,"typeClass":"primitive","value":"Medicine quality"}},{"topicClassValue":{"typeName":"topicClassValue","multiple":false,"typeClass":"primitive","value":"Substandard and falsified medicines"}},{"topicClassValue":{"typeName":"topicClassValue","multiple":false,"typeClass":"primitive","value":"SSFFC"}}]},{"typeName":"publication","multiple":true,"typeClass":"compound","value":[{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study. Submitted draft paper."}}]},{"typeName":"language","multiple":true,"typeClass":"controlledVocabulary","value":["English"]},{"typeName":"producer","multiple":true,"typeClass":"compound","value":[{"producerName":{"typeName":"producerName","multiple":false,"typeClass":"primitive","value":"Pisani, Elizabeth"}}]},{"typeName":"productionDate","multiple":false,"typeClass":"primitive","value":"2018-07-27"},{"typeName":"productionPlace","multiple":false,"typeClass":"primitive","value":"London"},{"typeName":"contributor","multiple":true,"typeClass":"compound","value":[{"contributorType":{"typeName":"contributorType","multiple":false,"typeClass":"controlledVocabulary","value":"Project Leader"}}]},{"typeName":"grantNumber","multiple":true,"typeClass":"compound","value":[{"grantNumberAgency":{"typeName":"grantNumberAgency","multiple":false,"typeClass":"primitive","value":"Wellcome Trust"},"grantNumberValue":{"typeName":"grantNumberValue","multiple":false,"typeClass":"primitive","value":"209930_Z_17_Z"}}]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Pisani, Elizabeth"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2018-07-27"},{"typeName":"kindOfData","multiple":true,"typeClass":"primitive","value":["Supporting data for qualitative study of medicine quality in China, Indonesia, Romania and Turkey."]}]}},"files":[{"description":"This draft paper describes a study of the political and economic forces driving the markets for substandard and falsified medicines in four middle-income countries: China, Indonesia, Romania and Turkey","label":"01_Draft_Paper_Pisani_et_al_Political_economy_of_medicine_quality.docx","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3332991,"persistentId":"doi:10.7910/DVN/ZSCLQA/ZCMPF8","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/ZCMPF8","filename":"01_Draft_Paper_Pisani_et_al_Political_economy_of_medicine_quality.docx","contentType":"application/vnd.openxmlformats-officedocument.wordprocessingml.document","filesize":101052,"description":"This draft paper describes a study of the political and economic forces driving the markets for substandard and falsified medicines in four middle-income countries: China, Indonesia, Romania and Turkey","storageIdentifier":"s3://dvn-cloud:167c1fc21de-a17a88898e05","rootDataFileId":-1,"md5":"ef113f46ceb8cc41bd09219d25805ef8","checksum":{"type":"MD5","value":"ef113f46ceb8cc41bd09219d25805ef8"}}},{"description":"This video provides a narrated walk-through of a framework that uses political economy analysis to assess the risk of substandard or falsified medicines entering a national market.","label":"02_Medicine_quality_risk_assesment_narrated_video.mov","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3224845,"persistentId":"doi:10.7910/DVN/ZSCLQA/GGP8EP","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/GGP8EP","filename":"02_Medicine_quality_risk_assesment_narrated_video.mov","contentType":"video/quicktime","filesize":51330634,"description":"This video provides a narrated walk-through of a framework that uses political economy analysis to assess the risk of substandard or falsified medicines entering a national market.","storageIdentifier":"s3://dvn-cloud:165e7b1929b-7e4848bb5867","rootDataFileId":-1,"md5":"679ae36345ffa8c14b0181ba041e2c29","checksum":{"type":"MD5","value":"679ae36345ffa8c14b0181ba041e2c29"}}},{"description":"This video summarises the risks posed to the quality of medicines as Indonesia rapidly scales up its national health insurance programme.","label":"03_Medicine_quality_in_Indonesia.mov","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3323583,"persistentId":"doi:10.7910/DVN/ZSCLQA/PYZFG3","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/PYZFG3","filename":"03_Medicine_quality_in_Indonesia.mov","contentType":"video/quicktime","filesize":91083955,"description":"This video summarises the risks posed to the quality of medicines as Indonesia rapidly scales up its national health insurance programme.","storageIdentifier":"s3://dvn-cloud:1677bae19ad-2c2c7fb5b0d3","rootDataFileId":-1,"md5":"d7266d0943ed7f64a6e32835b614bbeb","checksum":{"type":"MD5","value":"d7266d0943ed7f64a6e32835b614bbeb"}}},{"description":"Video: Hasil penelitian tentang risiko terhadap obat palsu dan kurang bermutu di Indonesia, dalam era JKN","label":"04_Video_kwalitas_obat_jaman_JKN.mov","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3333002,"persistentId":"doi:10.7910/DVN/ZSCLQA/MKIFEX","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/MKIFEX","filename":"04_Video_kwalitas_obat_jaman_JKN.mov","contentType":"video/quicktime","filesize":131117425,"description":"Video: Hasil penelitian tentang risiko terhadap obat palsu dan kurang bermutu di Indonesia, dalam era JKN","storageIdentifier":"s3://dvn-cloud:167c2116325-b56b8b876c6a","rootDataFileId":-1,"md5":"4267e844bb695fe546230cf2ad126d83","checksum":{"type":"MD5","value":"4267e844bb695fe546230cf2ad126d83"}}},{"description":"Colour-coded version of a framework to assess the risk of substandard and falsified medicines in a country. Accompanies Pisani et al: The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study,","label":"05_Medicine_quality_Figure1_colour.jpg","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3226154,"persistentId":"doi:10.7910/DVN/ZSCLQA/X3DWVT","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/X3DWVT","filename":"05_Medicine_quality_Figure1_colour.jpg","contentType":"image/jpeg","filesize":1520395,"description":"Colour-coded version of a framework to assess the risk of substandard and falsified medicines in a country. Accompanies Pisani et al: The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study,","storageIdentifier":"s3://dvn-cloud:165f69d52a8-b29cffc1a7e8","rootDataFileId":3212896,"previousDataFileId":3212896,"md5":"37ba69dffecd1547e9c863676e663bbc","checksum":{"type":"MD5","value":"37ba69dffecd1547e9c863676e663bbc"}}},{"description":"Colour-coded version of a framework to assess the risk of substandard and falsified medicines in a country. Accompanies Pisani et al: The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study","label":"06_Medicine_quality_Figure2_colour-1.jpg","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3226155,"persistentId":"doi:10.7910/DVN/ZSCLQA/FGKQHZ","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/FGKQHZ","filename":"06_Medicine_quality_Figure2_colour-1.jpg","contentType":"image/jpeg","filesize":4069612,"description":"Colour-coded version of a framework to assess the risk of substandard and falsified medicines in a country. Accompanies Pisani et al: The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study","storageIdentifier":"s3://dvn-cloud:165f6a17734-45358336cb79","rootDataFileId":3212897,"previousDataFileId":3212897,"md5":"d09c33328da952d8d319d434f246d9d4","checksum":{"type":"MD5","value":"d09c33328da952d8d319d434f246d9d4"}}},{"description":"These data provide supplementary information for the paper \"The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study\" by Pisani et al. \r\n\r\nWe provide an annotated version of the medicine quality risk assessment framework based on case studies in Indonesia, Turkey and Romania","label":"07_Pisani_medicine_quality_Country_Annex.pdf","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3207835,"persistentId":"doi:10.7910/DVN/ZSCLQA/WHJG8G","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/WHJG8G","filename":"07_Pisani_medicine_quality_Country_Annex.pdf","contentType":"application/pdf","filesize":905480,"description":"These data provide supplementary information for the paper \"The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study\" by Pisani et al. \r\n\r\nWe provide an annotated version of the medicine quality risk assessment framework based on case studies in Indonesia, Turkey and Romania","storageIdentifier":"s3://dvn-cloud:16542c70c3c-14818418858a","rootDataFileId":-1,"md5":"0dec4c0a1cbe4a2d3c5e4019dfe2d9a9","checksum":{"type":"MD5","value":"0dec4c0a1cbe4a2d3c5e4019dfe2d9a9"}}},{"description":"These data provide supplementary information for the paper \"The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study\" by Pisani et al. \r\n\r\nWe provide an annotated version of the medicine quality risk assessment framework illustrating the pathways through which specific substandard and falsified medicines came to market in the United States of America, Pakistan, and the Democratic Republic of Congo.","label":"08_Pisani_medicine_quality_GSMS_Annex.pdf","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3207836,"persistentId":"doi:10.7910/DVN/ZSCLQA/AATNE2","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/AATNE2","filename":"08_Pisani_medicine_quality_GSMS_Annex.pdf","contentType":"application/pdf","filesize":609147,"description":"These data provide supplementary information for the paper \"The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study\" by Pisani et al. \r\n\r\nWe provide an annotated version of the medicine quality risk assessment framework illustrating the pathways through which specific substandard and falsified medicines came to market in the United States of America, Pakistan, and the Democratic Republic of Congo.","storageIdentifier":"s3://dvn-cloud:16542c727f8-b51fed0234d5","rootDataFileId":-1,"md5":"ddb434afb47c1ced6e8e1583781c5ca1","checksum":{"type":"MD5","value":"ddb434afb47c1ced6e8e1583781c5ca1"}}},{"description":"This provides the NVivo coding structure and log file of changes to code for data associated with the literature review and country case studies.","label":"09_Medicine_quality_coding_structure.docx","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3208196,"persistentId":"doi:10.7910/DVN/ZSCLQA/EYTCZU","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/EYTCZU","filename":"09_Medicine_quality_coding_structure.docx","contentType":"application/vnd.openxmlformats-officedocument.wordprocessingml.document","filesize":60019,"description":"This provides the NVivo coding structure and log file of changes to code for data associated with the literature review and country case studies.","storageIdentifier":"s3://dvn-cloud:16547cf4d33-1950ba25fe1a","rootDataFileId":-1,"md5":"224b4a0e59cd4f5c0240044acb339854","checksum":{"type":"MD5","value":"224b4a0e59cd4f5c0240044acb339854"}}},{"description":"This file contains bibliographic data for over 840 references relevant to substandard and falsified medicines, for download into reference management software. It accompanies the paper \"The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study\" by Pisani et al. \r\n","label":"10_Medicine_quality_bibliography.ris","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3207837,"persistentId":"doi:10.7910/DVN/ZSCLQA/VPHBYS","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/VPHBYS","filename":"10_Medicine_quality_bibliography.ris","contentType":"application/x-research-info-systems","filesize":607461,"description":"This file contains bibliographic data for over 840 references relevant to substandard and falsified medicines, for download into reference management software. It accompanies the paper \"The political economy of substandard and falsified medicines: an evidence-informed risk-assessment framework based on a multi-country study\" by Pisani et al. \r\n","storageIdentifier":"s3://dvn-cloud:16542c74389-14fb47d3bc56","rootDataFileId":-1,"md5":"386d1393943d16bf384b11d823169db7","checksum":{"type":"MD5","value":"386d1393943d16bf384b11d823169db7"}}},{"description":"This supplements the methods section of the paper \"The political economy of substandard and falsified medicines\". It provides additional details on the researcher backgrounds, interviewee characteristics and interview settings, in accordance with the COREQ guidelines for the reporting of qualitative research.","label":"11_COREQ_medicine_quality_study_info_form.docx","restricted":false,"version":1,"datasetVersionId":150442,"dataFile":{"id":3196264,"persistentId":"doi:10.7910/DVN/ZSCLQA/PQ7MFZ","pidURL":"https://doi.org/10.7910/DVN/ZSCLQA/PQ7MFZ","filename":"11_COREQ_medicine_quality_study_info_form.docx","contentType":"application/vnd.openxmlformats-officedocument.wordprocessingml.document","filesize":31764,"description":"This supplements the methods section of the paper \"The political economy of substandard and falsified medicines\". It provides additional details on the researcher backgrounds, interviewee characteristics and interview settings, in accordance with the COREQ guidelines for the reporting of qualitative research.","storageIdentifier":"s3://dvn-cloud:164dccbea07-4bafeb908af3","rootDataFileId":-1,"md5":"7bd65fe3ca72b3116ca9fc08f2b7f543","checksum":{"type":"MD5","value":"7bd65fe3ca72b3116ca9fc08f2b7f543"}}}]}}}